152 related articles for article (PubMed ID: 37748692)
21. Performance of cystatin C- and creatinine-based estimated glomerular filtration rate equations depends on patient characteristics.
Meeusen JW; Rule AD; Voskoboev N; Baumann NA; Lieske JC
Clin Chem; 2015 Oct; 61(10):1265-72. PubMed ID: 26240296
[TBL] [Abstract][Full Text] [Related]
22. The value of serum cystatin C in early evaluation of renal insufficiency in patients undergoing chemotherapy: a systematic review and meta-analysis.
He L; Li J; Zhan J; Yi F; Fan X; Wei Y; Zhang W
Cancer Chemother Pharmacol; 2019 Mar; 83(3):561-571. PubMed ID: 30610366
[TBL] [Abstract][Full Text] [Related]
23. Performance of serum cystatin C versus serum creatinine as a marker of glomerular filtration rate as measured by inulin renal clearance.
Horio M; Imai E; Yasuda Y; Watanabe T; Matsuo S
Clin Exp Nephrol; 2011 Dec; 15(6):868-76. PubMed ID: 21861242
[TBL] [Abstract][Full Text] [Related]
24. Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment.
Coll E; Botey A; Alvarez L; Poch E; Quintó L; Saurina A; Vera M; Piera C; Darnell A
Am J Kidney Dis; 2000 Jul; 36(1):29-34. PubMed ID: 10873868
[TBL] [Abstract][Full Text] [Related]
25. Self-reported Race, Serum Creatinine, Cystatin C, and GFR in Children and Young Adults With Pediatric Kidney Diseases: A Report From the Chronic Kidney Disease in Children (CKiD) Study.
Ng DK; Furth SL; Warady BA; Crews DC; Seegmiller JC; Schwartz GJ;
Am J Kidney Dis; 2022 Aug; 80(2):174-185.e1. PubMed ID: 34974031
[TBL] [Abstract][Full Text] [Related]
26. Cystatin C and glomerular filtration rate in the cardiac surgery with cardiopulmonary bypass.
Felicio ML; Andrade RR; Castiglia YM; Silva MA; Vianna PT; Martins AS
Rev Bras Cir Cardiovasc; 2009; 24(3):305-11. PubMed ID: 20011875
[TBL] [Abstract][Full Text] [Related]
27. [Cystatin C as a measure of glomerular filtration in patients with kidney transplants].
Jovanović D; Krstivojević P; Obradović I; Djurdjević V; Blagojević-Lazić R; Djukanović L
Srp Arh Celok Lek; 2003; 131(5-6):211-4. PubMed ID: 14692126
[TBL] [Abstract][Full Text] [Related]
28. Estimated glomerular filtration rate and urine biomarkers in patients with single-ventricle Fontan circulation.
Opotowsky AR; Baraona FR; Mc Causland FR; Loukas B; Landzberg E; Landzberg MJ; Sabbisetti V; Waikar SS
Heart; 2017 Mar; 103(6):434-442. PubMed ID: 27670967
[TBL] [Abstract][Full Text] [Related]
29. Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.
Oddoze C; Morange S; Portugal H; Berland Y; Dussol B
Am J Kidney Dis; 2001 Aug; 38(2):310-6. PubMed ID: 11479157
[TBL] [Abstract][Full Text] [Related]
30. Creatinine-Based and Cystatin C-Based GFR Estimating Equations and Their Non-GFR Determinants in Kidney Transplant Recipients.
Keddis MT; Amer H; Voskoboev N; Kremers WK; Rule AD; Lieske JC
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1640-1649. PubMed ID: 27340283
[TBL] [Abstract][Full Text] [Related]
31. Plasma cystatin C as a marker for estimated glomerular filtration rate assessment in HIV-1-infected patients treated with dolutegravir-based ART.
Palich R; Tubiana R; Abdi B; Mestari F; Guiguet M; Imbert-Bismut F; Katlama C; Bonnefont-Rousselot D; Isnard-Bagnis C
J Antimicrob Chemother; 2018 Jul; 73(7):1935-1939. PubMed ID: 29688533
[TBL] [Abstract][Full Text] [Related]
32. Serum cystatin C is a more sensitive and more accurate marker of glomerular filtration rate than enzymatic measurements of creatinine in renal transplantation.
Christensson A; Ekberg J; Grubb A; Ekberg H; Lindström V; Lilja H
Nephron Physiol; 2003; 94(2):p19-27. PubMed ID: 12845219
[TBL] [Abstract][Full Text] [Related]
33. Estimating GFR prior to contrast medium examinations--what the radiologist needs to know!
Nyman U; Björk J; Bäck SE; Sterner G; Grubb A
Eur Radiol; 2016 Feb; 26(2):425-35. PubMed ID: 26017739
[TBL] [Abstract][Full Text] [Related]
34. Kidney function estimating equations in patients with chronic kidney disease.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Int J Clin Pract; 2011 Apr; 65(4):458-64. PubMed ID: 21401834
[TBL] [Abstract][Full Text] [Related]
35. Serum cystatin C as an endogenous marker of renal function in patients with mild to moderate impairment of kidney function.
Hojs R; Bevc S; Ekart R; Gorenjak M; Puklavec L
Nephrol Dial Transplant; 2006 Jul; 21(7):1855-62. PubMed ID: 16524933
[TBL] [Abstract][Full Text] [Related]
36. Performance of creatinine- or cystatin C-based equations to estimate glomerular filtration rate in sub-Saharan African populations.
Bukabau JB; Yayo E; Gnionsahé A; Monnet D; Pottel H; Cavalier E; Nkodila A; Makulo JRR; Mokoli VM; Lepira FB; Nseka NM; Krzesinski JM; Sumaili EK; Delanaye P
Kidney Int; 2019 May; 95(5):1181-1189. PubMed ID: 30910379
[TBL] [Abstract][Full Text] [Related]
37. Cystatin C Is a More Reliable Biomarker for Determining eGFR to Support Drug Development Studies.
Kar S; Paglialunga S; Islam R
J Clin Pharmacol; 2018 Oct; 58(10):1239-1247. PubMed ID: 29775220
[TBL] [Abstract][Full Text] [Related]
38. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.
Shlipak MG; Katz R; Sarnak MJ; Fried LF; Newman AB; Stehman-Breen C; Seliger SL; Kestenbaum B; Psaty B; Tracy RP; Siscovick DS
Ann Intern Med; 2006 Aug; 145(4):237-46. PubMed ID: 16908914
[TBL] [Abstract][Full Text] [Related]
39. Drug-induced reduction in estimated glomerular filtration rate in patients with ALK-positive non-small cell lung cancer treated with the ALK inhibitor crizotinib.
Brosnan EM; Weickhardt AJ; Lu X; Maxon DA; Barón AE; Chonchol M; Camidge DR
Cancer; 2014 Mar; 120(5):664-74. PubMed ID: 24258622
[TBL] [Abstract][Full Text] [Related]
40. Capmatinib-Induced Pseudo-Acute Kidney Injury: A Case Report.
Mohan A; Herrmann SM
Am J Kidney Dis; 2022 Jan; 79(1):120-124. PubMed ID: 34118303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
